Evado signs distribution deal

By Staff Writers
Monday, 14 April, 2008

Specialist life science training, quality assurance and regulatory compliance company SeerPharma has signed a re-seller agreement with Evado, a division of Australian company Invision IT Systems.

SeerPharma will distribute Evado's new web-based enterprise pre-clinical, clinical and mobile software modules in the SE Asian region. SeerPharma will also offer Evado as a software-as-a-service (SaaS) application to its medical device, biotechnology and life science clients.

Evado is a form-based technology that replaces the paper-based case report forms with easy to customise templates that are suitable for drug or device trials.

"Evado was created to provide a simple, easy-to-use, economical alternative to expensive clinical trial software," Evado's CEO Jennie Anderson said.

"Evado helps speed up clinical trials and assists researchers in the development of new medical therapies and medical devices by reducing costs and by improving data accuracy thereby achieving quicker regulatory approvals and time to market."

Related News

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd